Neogen (NEOG) Cash from Investing Activities (2010 - 2026)
Neogen's (NEOG) quarterly Cash from Investing Activities came in at -$11.6 million in Q1 2026, up 64.42% year-on-year from -$7.0 million in Q1 2025, and up 0.97% quarter-over-quarter from -$11.7 million in Q4 2025.
Neogen (NEOG) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Neogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$11.6 million for Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 64.42% year-over-year to -$11.6 million in Q1 2026; TTM through Feb 2026 was $58.6 million, a 158.13% increase from a year earlier, with the FY2025 full-year figure at -$99.2 million, down 238.45% from the prior year.
- Cash from Investing Activities grew to -$11.6 million in Q1 2026 per NEOG's latest filing, from -$11.7 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $97.7 million in Q3 2025 and bottomed at -$33.7 million in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$11.7 million (2025), against an average of $6.7 million.
- Across the five-year window, Cash from Investing Activities jumped 421.32% in 2022 and sank 354.84% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at $93.0 million in 2022, then tumbled by 87.6% to $11.5 million in 2023, then sank by 248.73% to -$17.2 million in 2024, then surged by 31.99% to -$11.7 million in 2025, then increased by 0.97% to -$11.6 million in 2026.
- Per Business Quant, the three latest NEOG Cash from Investing Activities figures stand at -$11.6 million (Q1 2026), -$11.7 million (Q4 2025), and $97.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Neogen | 2.05 Bn | 1.89 Bn | 99.00 Mn | -11.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -11.56 Mn |
| Feb 28, 2026 | -11.56 Mn |
| Nov 30, 2025 | -11.67 Mn |
| Nov 30, 2025 | -11.67 Mn |
| Aug 31, 2025 | 97.73 Mn |
| Aug 31, 2025 | 97.73 Mn |
| May 31, 2025 | -15.90 Mn |
| May 31, 2025 | -15.90 Mn |
| Feb 28, 2025 | -32.48 Mn |
| Feb 28, 2025 | -32.48 Mn |
| Nov 30, 2024 | -17.16 Mn |
| Nov 30, 2024 | -17.16 Mn |
| Aug 31, 2024 | -33.66 Mn |
| Aug 31, 2024 | -33.66 Mn |
| May 31, 2024 | -17.52 Mn |
| May 31, 2024 | -17.52 Mn |
| Feb 29, 2024 | -14.64 Mn |
| Feb 29, 2024 | -14.64 Mn |
| Nov 30, 2023 | 11.54 Mn |
| Nov 30, 2023 | 11.54 Mn |